I believe that sentiment_stocks pointed out a third major error. That was regarding the article saying that the IDH status of the DCVax-L Phase III trial patients was not disclosed.
But IDH status was clearly disclosed in the JAMA Oncology peer-reviewed article.
Market Data 
Markets 
AI
